-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JvBEA29ebHetaYBhbA2smKckvPIVDFzOV0x937IFAJ/2RqIbbTbrce3eGPD9jVcp zwU3+XRjcIw3F1YHoqXZ6w== /in/edgar/work/0000950130-00-005577/0000950130-00-005577.txt : 20001023 0000950130-00-005577.hdr.sgml : 20001023 ACCESSION NUMBER: 0000950130-00-005577 CONFORMED SUBMISSION TYPE: SC TO-T/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20001020 GROUP MEMBERS: SIEMENS AKTIENGESELLSCHAFT GROUP MEMBERS: SIEMENS CORPORATION GROUP MEMBERS: SIGMA ACQUISITION CORP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ACUSON CORP CENTRAL INDEX KEY: 0000717014 STANDARD INDUSTRIAL CLASSIFICATION: [3845 ] IRS NUMBER: 942784998 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-T/A SEC ACT: SEC FILE NUMBER: 005-37247 FILM NUMBER: 743272 BUSINESS ADDRESS: STREET 1: 1220 CHARLESTON RD STREET 2: PO BOX 7393 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94039 BUSINESS PHONE: 4159699112 MAIL ADDRESS: STREET 1: P O BOX 7393 STREET 2: 1220 CHARLESTON RD CITY: MOUNTAIN VIEW STATE: CA ZIP: 74039 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SIEMENS AKTIENGESELLSCHAFT CENTRAL INDEX KEY: 0000790925 STANDARD INDUSTRIAL CLASSIFICATION: [ ] FILING VALUES: FORM TYPE: SC TO-T/A BUSINESS ADDRESS: STREET 1: WITTE ISBACHERPLATZ 2 STREET 2: D-80333 CITY: MUNICH GERMANY SC TO-T/A 1 0001.txt AMENDMENT NO. 4 TO SCHEDULE TO SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________ AMENDMENT NO. 4 TO SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT PURSUANT TO SECTION 14(d)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Acuson Corporation (Name of Subject Company (Issuer)) Sigma Acquisition Corp. a wholly-owned subsidiary of Siemens Corporation an indirect wholly-owned subsidiary of Siemens Aktiengesellschaft (Names of Filing Persons (Offerors)) Common Stock, $0.0001 par value (Title of Class of Securities) 005113105 (CUSIP Number of class of securities) Kevin M. Royer Siemens Corporation 153 East 53/rd/ Street New York, New York 10022 (212) 258-4000 (Name, Address and Telephone No. of Person Authorized to Receive Notices and Communications on Behalf of Filing Persons) with a copy to: John A. Healy, Esq. Clifford Chance Rogers & Wells LLP 200 Park Avenue, New York, New York 10166 (212) 878-8000 _________________________ Calculation of Filing Fee - -------------------------------------------------------------------------------- Transaction Valuation Amount of Filing Fee $812,694,742 $162,539* - -------------------------------------------------------------------------------- * Previously paid. [_] Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer. Check the appropriate boxes below to designate any transactions to which the statement relates: [X] third-party tender offer subject to Rule 14d-1. [_] issuer tender offer subject to Rule 13e-4. [_] going-private transaction subject to Rule 13e-3. [_] amendment to Schedule 13D under Rule 13d-2. Check the following box if the filing is a final amendment reporting the results of the tender offer: [_] AMENDMENT NO. 4 TO SCHEDULE TO This Amendment No. 4 amends and supplements the Tender Offer Statement on Schedule TO, originally filed with the Securities and Exchange Commission (the "Commission") on October 5, 2000, as amended by Amendment No. 1 filed with the Commission on October 12, 2000, Amendment No. 2 filed with the Commission on October 13, 2000 and Amendment No. 3 filed with the Commission on October 19, 2000 (the "Schedule TO"), relating to the offer by Sigma Acquisition Corp., a Delaware corporation ("Purchaser"), which is a wholly-owned subsidiary of Siemens Corporation, a Delaware corporation ("Parent"), which is an indirect wholly-owned subsidiary of Siemens Aktiengesellschaft, a corporation formed under the laws of the Federal Republic of Germany ("Siemens AG"), to purchase all of the outstanding shares of common stock, par value $0.0001 per share ("Common Stock"), of Acuson Corporation, a Delaware corporation (the "Company"), together with the associated rights to purchase shares of series A preferred stock ("Rights") issued pursuant to the Amended and Restated Rights Agreement, dated as of November 5, 1998, between the Company and Fleet National Bank (f/k/a BankBoston, N.A.), as amended (the Common Stock and the Rights together being referred to herein as the "Shares"), at a price of $23.00 per Share, net to the seller in cash, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated October 5, 2000 (the "Offer to Purchase"), a copy of which was attached as Exhibit (a)(1) to the Schedule TO, and in the related Letter of Transmittal, a copy of which was attached to the Schedule TO as Exhibit (a)(2). Schedule TO The Schedule TO is hereby supplemented and/or amended as provided below. Item 11. Additional Information. Item 11 of the Schedule TO is amended by adding the following: For additional information regarding the re-filing of the Notification and Report Form by Siemens AG, see the text of the press release filed as an exhibit hereto. Item 12. Exhibits. Item 12 of the Schedule TO is amended by adding the following: (a)(9) Press release issued by Siemens AG, dated October 19, 2000 announcing the withdrawal and subsequent re-filing of the Notification and Report Form by Siemens AG pursuant to the HSR Act. -2- SIGNATURE After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 20, 2000 SIGMA ACQUISITION CORP. /s/ Michael W. Schiefen ------------------------------------- Name: Michael W. Schiefen Title: President /s/ E. Robert Lupone ------------------------------------- Name: E. Robert Lupone Title: Vice President SIEMENS CORPORATION /s/ Michael W. Schiefen ------------------------------------- Name: Michael W. Schiefen Title: Vice President-Corporate Development /s/ E. Robert Lupone ------------------------------------- Name: E. Robert Lupone Title: Senior Vice President, General Counsel and Secretary SIEMENS AKTIENGESELLSCHAFT /s/ Erich Reinhardt ------------------------------------- Name: Erich Reinhardt Title: Chief Executive Officer and Group President, Medical Engineering Division of Siemens /s/ Goetz Steinhardt ------------------------------------- Name: Goetz Steinhardt Title: Corporate Vice President, Medical Engineering Division of Siemens -3- EX-99.(A)(9) 2 0002.txt PRESS RELEASE ISSUED BY SIEMENS AG, DTD 10/19/2000 Exhibit (a)(9) FOR IMMEDIATE RELEASE INVESTOR CONTACT: Jon Einsidler Georgeson Shareholder Services Inc. (212) 440-9884 jeinsidler@georgeson.com ------------------------ PRESS CONTACT: Kimberly Cooper (732) 906-3802 Kimberly.cooper@sc.siemens.com ------------------------------ SIEMENS REFILES US ANTITRUST NOTIFICATION REGARDING ACUSON ERLANGEN, Germany, October 19, 2000 - After consultation with the Antitrust Division of the United States Department of Justice (the "Antitrust Division"), on October 18, 2000 Siemens AG withdrew and subsequently re-filed its Notification and Report Form filed pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") relating to its pending cash tender offer for all of the outstanding shares of Acuson Corporation. Siemens made such withdrawal and re-filing of its Notification in response to the Antitrust Division's request for additional time to review the Acuson transaction. Accordingly, the waiting period under the HSR Act will now expire at 11:59 p.m., New York City time, on November 2, 2000, unless early termination of the waiting period is granted or unless prior to that time Siemens AG receives a request for additional information or documentary material. Under the HSR Act, until the expiration of a 15-calendar day waiting period, no Shares may be purchased pursuant to Siemens' offer to purchase all of the outstanding shares of common stock (and associated rights) of Acuson at $23.00 per share. Nevertheless, the waiting period will still expire prior to the initial expiration of the offering period of Siemens' tender offer. -more- Siemens Refiles US Antitrust, page 2 ------------------------------------ Siemens' Medical Engineering Group (Med) is one of the largest global suppliers in the healthcare sector. The Group is renowned for its innovative products, services and complete solutions, ranging from imaging systems for diagnostics and therapy products for treatment to electromedicine and hearing instruments to IT solutions that optimize workflow and increase efficiency in hospitals, clinics and doctors' offices. This release is neither an offer to purchase nor a solicitation of an offer to sell securities of Acuson Corporation. The tender offer is being made solely by an offer to purchase and related letter of transmittal disseminated upon the commencement of the tender offer and amended from time to time. Shareholders of Acuson Corporation should read the tender offer statement because it contains important information. These documents are available to Acuson shareholders at no charge and are also available for free at the SEC's web site (http://www.sec.gov). ------------------ # # # Press releases issued are available on our web site at: http://www.usa.siemens.com/News_and_Press/RecentPressReleases.htm -----END PRIVACY-ENHANCED MESSAGE-----